Your browser doesn't support javascript.
loading
Effects of proprotein convertase subtilisin/kexin type 9 and nilotinib plasma concentrations on nilotinib-induced hypercholesterolaemia in patients with chronic myeloid leukaemia.
Abumiya, Maiko; Akamine, Yumiko; Sato, Shiori; Takahashi, Saori; Yoshioka, Tomoko; Kameoka, Yoshihiro; Takahashi, Naoto; Miura, Masatomo.
Afiliação
  • Abumiya M; Department of Pharmacy, Akita University Hospital, Akita, Japan.
  • Akamine Y; Department of Pharmacy, Akita University Hospital, Akita, Japan.
  • Sato S; Department of Pharmacy, Akita University Hospital, Akita, Japan.
  • Takahashi S; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
  • Yoshioka T; Clinical Research Promotion and Support Center, Akita University Hospital, Akita, Japan.
  • Kameoka Y; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
  • Takahashi N; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
  • Miura M; Clinical Research Promotion and Support Center, Akita University Hospital, Akita, Japan.
J Clin Pharm Ther ; 46(2): 382-387, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33108009

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Pró-Proteína Convertase 9 / Hipercolesterolemia / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Pró-Proteína Convertase 9 / Hipercolesterolemia / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article